Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
CIN L24230GJ1995PLC024288 Incorporated 20 January 1995 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹671.03 Cr
▲ 7.67% YoY
Computed EBITDA · FY 2026
₹131.14 Cr
▲ 5.78% YoY
Net profit · FY 2026
₹87.89 Cr
▲ 6.74% YoY
Authorised capital
₹32 Cr
Registered with MCA
Paid-up capital
₹20.03 Cr
Issued & subscribed
Open charges
₹117.64 Cr
Satisfied ₹47 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
1,531
Latest available

About Lincoln Pharmaceuticals Ltd

Data last updated: 14 July 2026

Lincoln Pharmaceuticals Ltd is a public limited company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 20 January 1995, the company has been in operation for over 31 years.

Registered with ROC Ahmedabad under CIN L24230GJ1995PLC024288. Listed.

Capital: an authorised share capital of ₹32 Cr and a paid-up capital of ₹20.03 Cr. It is led by directors including Hashmukhbhai Ishwarlal Patel and Ashish Rajanikant Patel.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Lincoln House Behind Satyam Complex Science City Road Sola, Ahmedabad, Gujarat, India – 380060.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹671.03 Cr, a growth of 7.67% compared to the previous year. The net worth stands at ₹757.63 Cr (up 12.8% YoY). Total assets are valued at ₹890.4 Cr (up 11.72% YoY).

The company has a workforce of approximately 1,531 employees as per the latest available data.

The company is associated with 1 brand - Lincoln Pharma. As per MCA filings, the company has open charges of ₹117.64 Cr and satisfied charges of ₹47 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lincolnpharma.com.

Company Details of Lincoln Pharmaceuticals Ltd
CIN L24230GJ1995PLC024288
Registration Number 024288
Incorporation Date 20 January 1995
ROC Ahmedabad
Listing Status Listed
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Mahendrabhai Gulabdas Patel Managing Director Hashmukhbhai Ishwarlal Patel Whole-Time Director Ashish Rajanikant Patel Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    lincolnpharma.com
  • Social Media
  • Registered Address
    Lincoln House Behind Satyam Complex Science City Road Sola, Ahmedabad, Gujarat, India – 380060
  • Industry
    Pharma, Drug Formulation & Development
Company report
Lincoln Pharmaceuticals Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Lincoln Pharmaceuticals Ltd report

Financials, compliance, directors, charges, ownership and filings for Lincoln Pharmaceuticals Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd operates one associated brand: Lincoln Pharma. These brands represent Lincoln Pharmaceuticals Ltd's diversified market presence and brand portfolio.

Brand Description Website
Lincoln Pharma
Non-beta lactam pharmaceutical formulations are manufactured in various forms. lincolnpharma.com

Business Activity of Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Lincoln Pharmaceuticals Ltd

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd is audited by M/S Samir M Shah & Associates (ICAI peer reviewed, certificate valid till 2029-04-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/S Samir M Shah & Associates (ICAI peer reviewed, certificate valid till 2029-04-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd is currently managed by 9 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Hashmukhbhai Ishwarlal Patel
Also directs: Zullinc Healthcare Llp, Cosmetics Concept Research Private Limited
Whole-Time Director 20 Jan 1995 31 Years 6 Months Current
Ashish Rajanikant Patel Whole-Time Director 14 Nov 2014 11 Years 9 Months Current
Munjal Mahendrabhai Patel
Also directs: Downtown Travels Llp, Downtown Finance Private Limited, Sunmed Corporation Llp and 1 more
Whole-Time Director 14 Nov 2014 11 Years 9 Months Current
Saurin Jagdish Bhai Parikh
Also directs: Global Park Developer Llp, Universal Industrial Park Llp, Pashupati Texspin Export Llp and 5 more
Director 27 Mar 2018 8 Years 4 Months Current
Rajanikant Gulabdas Patel Director 01 Oct 2008 17 Years 10 Months Current
Kishor Meghji Shah
Also directs: Downtown Finance Private Limited
Director 16 Aug 1995 31 Years 0 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Lincoln Pharmaceuticals Ltd FY 2026 filings available

Lincoln Pharmaceuticals Ltd reported revenue of ₹671.03 Cr (up 7.67% YoY) for FY 2026.

Revenue · FY 2026
₹671.03 Cr ▲ 7.67%
Profit · FY 2026
₹87.89 Cr ▲ 6.74%
Computed EBITDA · FY 2026
₹131.14 Cr ▲ 5.78%
Revenue₹ Cr · Consolidated0250500750FY 2023: ₹510 Cr510FY 2023FY 2024: ₹581 Cr · +13.8% YoY581+13.8%FY 2024FY 2025: ₹623 Cr · +7.4% YoY623+7.4%FY 2025FY 2026: ₹671 Cr · +7.7% YoY671+7.7%FY 2026
Net Profit₹ Cr · Consolidated050100FY 2023: ₹73 Cr72.9FY 2023FY 2024: ₹93 Cr · +28% YoY93.3+28%FY 2024FY 2025: ₹82 Cr · -11.7% YoY82.3-11.7%FY 2025FY 2026: ₹88 Cr · +6.7% YoY87.9+6.7%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200Q1'25: ₹147 Cr · +8.6% YoY147+8.6%Q1'25Q2'25: ₹161 Cr · +3.4% YoY161+3.4%Q2'25Q3'25: ₹147 Cr · +0.1% YoY147+0.1%Q3'25Q4'25: ₹168 Cr · +18% YoY168+18%Q4'25Q1'26: ₹154 Cr · +4.6% YoY154+4.6%Q1'26Q2'26: ₹163 Cr · +1.3% YoY163+1.3%Q2'26Q3'26: ₹166 Cr · +13.5% YoY166+13.5%Q3'26Q4'26: ₹187 Cr · +11.4% YoY187+11.4%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹671.03 Cr ₹623.23 Cr ₹580.55 Cr ₹510.31 Cr
Other Income ₹33.45 Cr ₹22.48 Cr ₹34.42 Cr ₹22.47 Cr
Total Income ₹704.48 Cr ₹645.71 Cr ₹614.97 Cr ₹532.78 Cr
Cost of Materials Consumed ₹239.57 Cr ₹213.94 Cr ₹201.12 Cr ₹177 Cr
Purchases of Stock-in-Trade ₹79.03 Cr ₹68.54 Cr ₹82.91 Cr ₹68.64 Cr
Changes in Inventories -₹7.44 Cr ₹8.84 Cr -₹5.7 Cr -₹4.24 Cr
Employee Benefit Expense ₹125.19 Cr ₹112.45 Cr ₹102.9 Cr ₹93.16 Cr
Finance Costs ₹1.01 Cr ₹1.88 Cr ₹1.46 Cr ₹2.03 Cr
Depreciation & Amortisation ₹14.5 Cr ₹12.9 Cr ₹10.62 Cr ₹9.17 Cr
Other Expenses ₹137 Cr ₹117.96 Cr ₹99.4 Cr ₹86.55 Cr
Total Expenses ₹588.86 Cr ₹536.52 Cr ₹492.73 Cr ₹432.3 Cr
Profit Before Exceptional Items & Tax ₹115.63 Cr ₹109.19 Cr ₹122.24 Cr ₹100.48 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹115.63 Cr ₹109.19 Cr ₹122.24 Cr ₹100.48 Cr
Total Tax Expense ₹27.73 Cr ₹26.84 Cr ₹28.94 Cr ₹27.58 Cr
Net Profit ₹87.89 Cr ₹82.35 Cr ₹93.3 Cr ₹72.9 Cr
  attributable to Owners ₹0 ₹0 ₹0 ₹0
  attributable to NCI ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹1.68 Cr ₹9.17 Lakh ₹6.11 Lakh -₹29.78 Lakh
Total Comprehensive Income ₹89.57 Cr ₹82.44 Cr ₹93.37 Cr ₹72.6 Cr
EBITDA (computed) ₹131.14 Cr ₹123.97 Cr ₹134.33 Cr ₹111.68 Cr
Basic EPS ₹43.88 ₹41.11 ₹46.58 ₹36.40
Diluted EPS ₹43.88 ₹41.11 ₹46.58 ₹36.40
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹890.4 Cr ₹797.01 Cr ₹700.29 Cr ₹587.42 Cr
Non-current Assets ₹307.35 Cr ₹297.07 Cr ₹253.55 Cr ₹220.21 Cr
Current Assets ₹583.06 Cr ₹499.94 Cr ₹446.74 Cr ₹367.21 Cr
Property, Plant & Equipment ₹190.03 Cr ₹181.53 Cr ₹179 Cr ₹150.23 Cr
Inventories ₹80.11 Cr ₹78.68 Cr ₹77.17 Cr ₹70.03 Cr
Trade Receivables ₹161.45 Cr ₹166.4 Cr ₹161.77 Cr ₹136.33 Cr
Cash & Equivalents ₹21.53 Cr ₹13.41 Cr ₹5.75 Cr ₹5.05 Cr
Equity (Net Worth) ₹757.63 Cr ₹671.67 Cr ₹592.84 Cr ₹502.47 Cr
Equity Share Capital ₹20.03 Cr ₹20.03 Cr ₹20.03 Cr ₹20.03 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹4.42 Cr ₹0 ₹1.07 Cr ₹2 Cr
Total Debt (computed) ₹4.42 Cr ₹0 ₹1.07 Cr ₹2 Cr
Current Liabilities ₹111.04 Cr ₹106.22 Cr ₹92.28 Cr ₹72.28 Cr
Total Liabilities ₹132.77 Cr ₹125.34 Cr ₹107.45 Cr ₹84.95 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow ₹106.36 Cr ₹93.02 Cr ₹63.22 Cr ₹39.26 Cr
Investing Cash Flow -₹98.4 Cr -₹78.95 Cr -₹57.34 Cr -₹36.64 Cr
Financing Cash Flow ₹15.89 Lakh -₹6.4 Cr -₹5.18 Cr -₹4.5 Cr
Capital Expenditure ₹25.43 Cr ₹19.03 Cr ₹39.48 Cr ₹14.28 Cr
Free Cash Flow (computed) ₹80.93 Cr ₹73.99 Cr ₹23.74 Cr ₹24.98 Cr
Dividends Paid ₹3.61 Cr ₹3.61 Cr ₹3 Cr ₹3 Cr
Net Change in Cash ₹8.11 Cr ₹7.67 Cr ₹69.52 Lakh -₹1.88 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹187.28 Cr ₹166.32 Cr ₹163.36 Cr ₹154.07 Cr ₹168.18 Cr ₹146.55 Cr ₹161.21 Cr ₹147.28 Cr ₹142.49 Cr ₹146.45 Cr ₹155.99 Cr ₹135.62 Cr
Other Income -₹4.2 Cr ₹15.15 Cr ₹7.23 Cr ₹15.27 Cr -₹6.88 Cr ₹8.97 Cr ₹9.98 Cr ₹10.41 Cr ₹7.02 Cr ₹11.02 Cr ₹8.69 Cr ₹7.69 Cr
Total Income ₹183.08 Cr ₹181.47 Cr ₹170.6 Cr ₹169.34 Cr ₹161.3 Cr ₹155.52 Cr ₹171.19 Cr ₹157.69 Cr ₹149.51 Cr ₹157.47 Cr ₹164.68 Cr ₹143.31 Cr
Cost of Materials Consumed ₹73.73 Cr ₹47.68 Cr ₹57.2 Cr ₹60.97 Cr ₹53.93 Cr ₹50.16 Cr ₹57.1 Cr ₹52.75 Cr ₹51.89 Cr ₹56.88 Cr ₹49.66 Cr ₹42.7 Cr
Purchases of Stock-in-Trade ₹16.45 Cr ₹25.03 Cr ₹21.72 Cr ₹15.83 Cr ₹14.75 Cr ₹18.61 Cr ₹21.86 Cr ₹13.33 Cr ₹17 Cr ₹30.51 Cr ₹19.96 Cr ₹15.44 Cr
Changes in Inventories -₹1.1 Cr ₹3.25 Cr -₹2.18 Cr -₹7.42 Cr ₹11.48 Cr -₹13.25 Lakh -₹6.66 Cr ₹4.16 Cr ₹4.69 Cr -₹20.3 Cr ₹4.2 Cr ₹5.71 Cr
Employee Benefit Expense ₹32.46 Cr ₹30.62 Cr ₹30.36 Cr ₹31.76 Cr ₹27.62 Cr ₹27.98 Cr ₹27.84 Cr ₹29.02 Cr ₹25.05 Cr ₹26.44 Cr ₹24.94 Cr ₹26.47 Cr
Finance Costs ₹27.44 Lakh ₹29.81 Lakh ₹23.07 Lakh ₹20.98 Lakh ₹36.68 Lakh ₹72.81 Lakh ₹34.88 Lakh ₹43.91 Lakh ₹49.92 Lakh ₹15.47 Lakh ₹39.42 Lakh ₹41.68 Lakh
Depreciation & Amortisation ₹3.68 Cr ₹3.72 Cr ₹3.62 Cr ₹3.48 Cr ₹3.23 Cr ₹3.22 Cr ₹3.22 Cr ₹3.22 Cr ₹2.69 Cr ₹2.81 Cr ₹2.58 Cr ₹2.55 Cr
Other Expenses ₹40.89 Cr ₹36.15 Cr ₹30.83 Cr ₹29.12 Cr ₹33.69 Cr ₹26.27 Cr ₹32.71 Cr ₹25.29 Cr ₹25.48 Cr ₹23.26 Cr ₹26.07 Cr ₹24.59 Cr
Total Expenses ₹166.38 Cr ₹146.75 Cr ₹141.79 Cr ₹133.95 Cr ₹145.06 Cr ₹126.84 Cr ₹136.41 Cr ₹128.21 Cr ₹127.3 Cr ₹119.76 Cr ₹127.81 Cr ₹117.86 Cr
Profit Before Exceptional Items & Tax ₹16.7 Cr ₹34.72 Cr ₹28.81 Cr ₹35.39 Cr ₹16.25 Cr ₹28.68 Cr ₹34.78 Cr ₹29.48 Cr ₹22.22 Cr ₹37.71 Cr ₹36.87 Cr ₹25.45 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹16.7 Cr ₹34.72 Cr ₹28.81 Cr ₹35.39 Cr ₹16.25 Cr ₹28.68 Cr ₹34.78 Cr ₹29.48 Cr ₹22.22 Cr ₹37.71 Cr ₹36.87 Cr ₹25.45 Cr
Total Tax Expense ₹5.07 Cr ₹6.12 Cr ₹8.83 Cr ₹7.71 Cr ₹4.67 Cr ₹7.91 Cr ₹8.45 Cr ₹5.81 Cr ₹3.62 Cr ₹9.67 Cr ₹9.21 Cr ₹6.43 Cr
Net Profit ₹11.63 Cr ₹28.6 Cr ₹19.98 Cr ₹27.68 Cr ₹11.58 Cr ₹20.77 Cr ₹26.33 Cr ₹23.67 Cr ₹18.6 Cr ₹28.04 Cr ₹27.65 Cr ₹19.01 Cr
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹1.61 Cr ₹2.29 Lakh ₹2.29 Lakh ₹2.29 Lakh ₹4.59 Lakh ₹1.52 Lakh ₹1.53 Lakh ₹1.53 Lakh ₹28.44 Lakh -₹7.44 Lakh -₹7.45 Lakh -₹7.44 Lakh
Total Comprehensive Income ₹13.24 Cr ₹28.62 Cr ₹20.01 Cr ₹27.7 Cr ₹11.62 Cr ₹20.78 Cr ₹26.35 Cr ₹23.69 Cr ₹18.88 Cr ₹27.97 Cr ₹27.58 Cr ₹18.94 Cr
EBITDA (computed) ₹20.66 Cr ₹38.74 Cr ₹32.66 Cr ₹39.08 Cr ₹19.84 Cr ₹32.63 Cr ₹38.36 Cr ₹33.14 Cr ₹25.4 Cr ₹40.68 Cr ₹39.84 Cr ₹28.41 Cr
Basic EPS ₹5.81 ₹14.28 ₹9.98 ₹13.82 ₹5.78 ₹10.37 ₹13.15 ₹11.82 ₹9.28 ₹14.00 ₹13.81 ₹9.49
Diluted EPS ₹5.81 ₹14.28 ₹9.98 ₹13.82 ₹5.78 ₹10.37 ₹13.15 ₹11.82 ₹9.28 ₹14.00 ₹13.81 ₹9.49
Latest 12 quarters shown of 19 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹671.03 Cr ₹623.23 Cr ₹580.55 Cr ₹510.31 Cr ₹472.08 Cr ₹413.06 Cr ₹376.09 Cr
Other Income ₹33.45 Cr ₹22.48 Cr ₹34.42 Cr ₹22.48 Cr ₹10 Cr ₹6.77 Cr ₹12.13 Cr
Total Income ₹704.48 Cr ₹645.71 Cr ₹614.97 Cr ₹532.79 Cr ₹482.08 Cr ₹419.82 Cr ₹388.22 Cr
Cost of Materials Consumed ₹239.57 Cr ₹213.94 Cr ₹201.12 Cr ₹177 Cr ₹158.48 Cr ₹95.5 Cr ₹101.97 Cr
Purchases of Stock-in-Trade ₹79.03 Cr ₹68.54 Cr ₹82.91 Cr ₹68.64 Cr ₹73.67 Cr ₹104 Cr ₹90.66 Cr
Changes in Inventories -₹7.44 Cr ₹8.84 Cr -₹5.7 Cr -₹4.24 Cr -₹13.57 Cr ₹1.35 Cr -₹5.86 Cr
Employee Benefit Expense ₹125.19 Cr ₹112.45 Cr ₹102.9 Cr ₹93.16 Cr ₹70.47 Cr ₹56.47 Cr ₹54.9 Cr
Finance Costs ₹1.01 Cr ₹1.88 Cr ₹1.46 Cr ₹2.03 Cr ₹1.45 Cr ₹1.44 Cr ₹1.98 Cr
Depreciation & Amortisation ₹14.5 Cr ₹12.9 Cr ₹10.62 Cr ₹9.17 Cr ₹8.09 Cr ₹5.67 Cr ₹5.47 Cr
Other Expenses ₹137 Cr ₹117.96 Cr ₹99.4 Cr ₹86.59 Cr ₹87.56 Cr ₹74.38 Cr ₹75.04 Cr
Total Expenses ₹588.86 Cr ₹536.52 Cr ₹492.73 Cr ₹432.34 Cr ₹386.15 Cr ₹338.81 Cr ₹324.17 Cr
Profit Before Exceptional Items & Tax ₹115.63 Cr ₹109.19 Cr ₹122.24 Cr ₹100.46 Cr ₹95.93 Cr ₹81.01 Cr ₹64.05 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹115.63 Cr ₹109.19 Cr ₹122.24 Cr ₹100.46 Cr ₹95.93 Cr ₹81.01 Cr ₹64.05 Cr
Total Tax Expense ₹27.73 Cr ₹26.84 Cr ₹28.94 Cr ₹27.56 Cr ₹26.57 Cr ₹20.61 Cr ₹14.48 Cr
Net Profit ₹87.89 Cr ₹82.35 Cr ₹93.3 Cr ₹72.9 Cr ₹69.36 Cr ₹60.41 Cr ₹49.56 Cr
  attributable to Owners - - - - - - ₹0
  attributable to NCI - - - - - - ₹0
Other Comprehensive Income ₹1.68 Cr ₹9.17 Lakh ₹6.11 Lakh -₹29.78 Lakh ₹13 Lakh ₹5.21 Lakh -₹43.94 Lakh
Total Comprehensive Income ₹89.57 Cr ₹82.44 Cr ₹93.37 Cr ₹72.6 Cr ₹69.49 Cr ₹60.46 Cr ₹49.12 Cr
EBITDA (computed) ₹131.14 Cr ₹123.97 Cr ₹134.33 Cr ₹111.65 Cr ₹105.47 Cr ₹88.12 Cr ₹71.5 Cr
Basic EPS ₹43.88 ₹41.11 ₹46.58 ₹36.40 ₹34.63 ₹30.20 ₹24.78
Diluted EPS ₹43.88 ₹41.11 ₹46.58 ₹36.40 ₹34.63 ₹30.20 ₹24.78
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹890.26 Cr ₹796.87 Cr ₹700.15 Cr ₹587.26 Cr
Non-current Assets ₹307.4 Cr ₹297.12 Cr ₹253.6 Cr ₹220.26 Cr
Current Assets ₹582.87 Cr ₹499.75 Cr ₹446.55 Cr ₹367 Cr
Property, Plant & Equipment ₹190.03 Cr ₹181.53 Cr ₹179 Cr ₹150.23 Cr
Inventories ₹80.11 Cr ₹78.68 Cr ₹77.17 Cr ₹70.03 Cr
Trade Receivables ₹160.58 Cr ₹165.53 Cr ₹160.9 Cr ₹135.47 Cr
Cash & Equivalents ₹21.09 Cr ₹12.97 Cr ₹5.31 Cr ₹4.58 Cr
Equity (Net Worth) ₹757.63 Cr ₹671.67 Cr ₹592.84 Cr ₹502.47 Cr
Equity Share Capital ₹20.03 Cr ₹20.03 Cr ₹20.03 Cr ₹20.03 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹4.42 Cr ₹0 ₹1.07 Cr ₹2 Cr
Total Debt (computed) ₹4.42 Cr ₹0 ₹1.07 Cr ₹2 Cr
Current Liabilities ₹110.9 Cr ₹106.08 Cr ₹92.14 Cr ₹72.12 Cr
Total Liabilities ₹132.63 Cr ₹125.2 Cr ₹107.31 Cr ₹84.78 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹106.36 Cr ₹93.02 Cr ₹63.24 Cr ₹39.16 Cr ₹76.18 Cr
Investing Cash Flow -₹98.4 Cr -₹78.95 Cr -₹57.34 Cr -₹36.64 Cr -₹78.08 Cr
Financing Cash Flow ₹15.9 Lakh -₹6.4 Cr -₹5.18 Cr -₹4.5 Cr -₹2.56 Cr
Capital Expenditure ₹25.43 Cr ₹19.03 Cr ₹39.48 Cr ₹14.28 Cr ₹45.53 Cr
Free Cash Flow (computed) ₹80.93 Cr ₹73.99 Cr ₹23.77 Cr ₹24.87 Cr ₹30.66 Cr
Dividends Paid ₹3.61 Cr ₹3.61 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Net Change in Cash ₹8.12 Cr ₹7.67 Cr ₹72.54 Lakh -₹1.99 Cr -₹4.46 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹187.28 Cr ₹166.32 Cr ₹163.36 Cr ₹154.07 Cr ₹168.18 Cr ₹146.55 Cr ₹161.21 Cr ₹147.28 Cr ₹142.49 Cr ₹146.45 Cr ₹155.99 Cr ₹135.62 Cr
Other Income -₹4.2 Cr ₹15.15 Cr ₹7.23 Cr ₹15.27 Cr -₹6.88 Cr ₹8.97 Cr ₹9.98 Cr ₹10.41 Cr ₹7.02 Cr ₹11.02 Cr ₹8.69 Cr ₹7.69 Cr
Total Income ₹183.08 Cr ₹181.47 Cr ₹170.6 Cr ₹169.34 Cr ₹161.3 Cr ₹155.52 Cr ₹171.19 Cr ₹157.69 Cr ₹149.51 Cr ₹157.47 Cr ₹164.68 Cr ₹143.31 Cr
Cost of Materials Consumed ₹73.73 Cr ₹47.68 Cr ₹57.2 Cr ₹60.97 Cr ₹53.93 Cr ₹50.16 Cr ₹57.1 Cr ₹52.75 Cr ₹51.89 Cr ₹56.88 Cr ₹49.66 Cr ₹42.7 Cr
Purchases of Stock-in-Trade ₹16.45 Cr ₹25.03 Cr ₹21.72 Cr ₹15.83 Cr ₹14.75 Cr ₹18.61 Cr ₹21.86 Cr ₹13.33 Cr ₹17 Cr ₹30.51 Cr ₹19.96 Cr ₹15.44 Cr
Changes in Inventories -₹1.1 Cr ₹3.25 Cr -₹2.18 Cr -₹7.42 Cr ₹11.48 Cr -₹13.25 Lakh -₹6.66 Cr ₹4.16 Cr ₹4.69 Cr -₹20.3 Cr ₹4.2 Cr ₹5.71 Cr
Employee Benefit Expense ₹32.46 Cr ₹30.62 Cr ₹30.36 Cr ₹31.76 Cr ₹27.62 Cr ₹27.98 Cr ₹27.84 Cr ₹29.02 Cr ₹25.05 Cr ₹26.44 Cr ₹24.94 Cr ₹26.47 Cr
Finance Costs ₹27.43 Lakh ₹29.81 Lakh ₹23.07 Lakh ₹20.98 Lakh ₹36.67 Lakh ₹72.81 Lakh ₹34.88 Lakh ₹43.91 Lakh ₹49.91 Lakh ₹15.47 Lakh ₹39.42 Lakh ₹41.46 Lakh
Depreciation & Amortisation ₹3.68 Cr ₹3.72 Cr ₹3.62 Cr ₹3.48 Cr ₹3.23 Cr ₹3.22 Cr ₹3.22 Cr ₹3.22 Cr ₹2.69 Cr ₹2.81 Cr ₹2.58 Cr ₹2.55 Cr
Other Expenses ₹40.89 Cr ₹36.15 Cr ₹30.83 Cr ₹29.12 Cr ₹33.69 Cr ₹26.27 Cr ₹32.71 Cr ₹25.29 Cr ₹25.48 Cr ₹23.26 Cr ₹26.07 Cr ₹24.59 Cr
Total Expenses ₹166.38 Cr ₹146.75 Cr ₹141.79 Cr ₹133.95 Cr ₹145.06 Cr ₹126.84 Cr ₹136.41 Cr ₹128.21 Cr ₹127.29 Cr ₹119.76 Cr ₹127.81 Cr ₹117.86 Cr
Profit Before Exceptional Items & Tax ₹16.7 Cr ₹34.72 Cr ₹28.81 Cr ₹35.39 Cr ₹16.25 Cr ₹28.68 Cr ₹34.78 Cr ₹29.48 Cr ₹22.22 Cr ₹37.71 Cr ₹36.87 Cr ₹25.45 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹16.7 Cr ₹34.72 Cr ₹28.81 Cr ₹35.39 Cr ₹16.25 Cr ₹28.68 Cr ₹34.78 Cr ₹29.48 Cr ₹22.22 Cr ₹37.71 Cr ₹36.87 Cr ₹25.45 Cr
Total Tax Expense ₹5.07 Cr ₹6.12 Cr ₹8.83 Cr ₹7.71 Cr ₹4.67 Cr ₹7.91 Cr ₹8.45 Cr ₹5.81 Cr ₹3.62 Cr ₹9.67 Cr ₹9.21 Cr ₹6.43 Cr
Net Profit ₹11.63 Cr ₹28.6 Cr ₹19.98 Cr ₹27.68 Cr ₹11.58 Cr ₹20.77 Cr ₹26.33 Cr ₹23.67 Cr ₹18.6 Cr ₹28.04 Cr ₹27.65 Cr ₹19.01 Cr
Other Comprehensive Income ₹1.61 Cr ₹2.29 Lakh ₹2.29 Lakh ₹2.29 Lakh ₹4.59 Lakh ₹1.52 Lakh ₹1.53 Lakh ₹1.53 Lakh ₹28.44 Lakh -₹7.44 Lakh -₹7.45 Lakh -₹7.44 Lakh
Total Comprehensive Income ₹13.24 Cr ₹28.62 Cr ₹20.01 Cr ₹27.7 Cr ₹11.62 Cr ₹20.78 Cr ₹26.35 Cr ₹23.69 Cr ₹18.88 Cr ₹27.97 Cr ₹27.58 Cr ₹18.94 Cr
EBITDA (computed) ₹20.66 Cr ₹38.74 Cr ₹32.66 Cr ₹39.08 Cr ₹19.84 Cr ₹32.63 Cr ₹38.36 Cr ₹33.14 Cr ₹25.4 Cr ₹40.68 Cr ₹39.84 Cr ₹28.41 Cr
Basic EPS ₹5.81 ₹14.28 ₹9.98 ₹13.82 ₹5.78 ₹10.37 ₹13.15 ₹11.82 ₹9.28 ₹14.00 ₹13.81 ₹9.49
Diluted EPS ₹5.81 ₹14.28 ₹9.98 ₹13.82 ₹5.78 ₹10.37 ₹13.15 ₹11.82 ₹9.28 ₹14.00 ₹13.81 ₹9.49
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Lincoln Pharmaceuticals Ltd. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Lincoln Pharmaceuticals Ltd

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 49.78%, foreign institutional investors hold 5.19%, domestic institutional investors hold 1.09%, retail and other public shareholders hold 43.94% of Lincoln Pharmaceuticals Ltd. The company had 28,303 shareholders on record.

Promoters: 49.78%DII (Domestic Institutional): 1.09%FII (Foreign Institutional): 5.19%Retail & Others: 43.94%
Mar 2026
QUARTER
49.78% Promoters
1.09% DII (Domestic Institutional)
5.19% FII (Foreign Institutional)
43.94% Retail & Others
Promoter holding - history
Now 49.78% · Mar 2026High 49.80% · Sep 2023Low 31.43% · Mar 2018
30%35.3%40.5%45.8%51%Dec 2015Mar 2018Sep 2020Mar 2023Sep 2025Dec 2015: 34.97%Mar 2016: 34.93%Jun 2016: 34.93%Sep 2016: 34.91%Oct 2016: 32.47%Dec 2016: 32.47%Mar 2017: 32.46%Jun 2017: 32.46%Sep 2017: 32.47%Dec 2017: 32.72%Mar 2018: 31.43%Jun 2018: 31.68%Sep 2018: 31.68%Dec 2018: 31.68%Mar 2019: 31.68%Jun 2019: 31.68%Sep 2019: 31.68%Dec 2019: 31.68%Mar 2020: 31.63%Jun 2020: 31.63%Sep 2020: 31.68%Dec 2020: 32.68%Mar 2021: 37.26%Jun 2021: 37.06%Sep 2021: 39.55%Dec 2021: 41.28%Mar 2022: 41.32%Jun 2022: 43.36%Sep 2022: 43.36%Dec 2022: 45.61%Mar 2023: 46.28%Jun 2023: 47.95%Sep 2023: 49.80%Dec 2023: 49.80%Mar 2024: 49.53%Jun 2024: 49.78%Sep 2024: 49.78%Dec 2024: 49.78%Mar 2025: 49.78%Jun 2025: 49.78%Sep 2025: 49.78%Dec 2025: 49.78%Mar 2026: 49.78%49.80%31.43%49.78%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters49.78%49.78%49.78%49.78%49.78%49.78%
Public50.22%50.22%50.22%50.22%50.22%50.22%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters49.78%49.78%49.53%46.28%41.32%37.26%31.63%31.68%31.43%32.46%34.93%
Public50.22%50.22%50.47%53.72%58.68%62.74%68.37%68.32%68.57%67.54%65.07%
Promoter change (YoY, %pts)+0.00+0.25+3.25+4.96+4.06+5.63-0.05+0.25-1.03-2.47-

Board & Governance of Lincoln Pharmaceuticals Ltd

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Lincoln Pharmaceuticals Ltd has 9 directors - 3 independent and 4 executive. The board is chaired by Kishorbhai Meghjibhai Shah.

DirectorPositionOn board sinceListed boards
Kishorbhai Meghjibhai Shah Non-Executive - Non Independent Director · Chairperson 1995-08-16 1
Mahendra Gulabdas Patel Executive Director · MD 1995-01-20 1
Hashmukh Ishwarlal Patel Executive Director 1995-01-20 1
Munjal Mahendra Patel Executive Director 2014-11-14 2
Ashish Rajnibhai Patel Executive Director 2014-11-14 1
Rajnikant Gulabdas Patel Non-Executive - Non Independent Director 1995-01-20 1
Saurin Jagdish Parikh Non-Executive - Independent Director 2018-03-27 2
Nareshkumar Pirabhai Suthar Non-Executive - Independent Director 2024-04-01 1
Seema Manubhai Mehta Non-Executive - Independent Director 2024-04-01 1
Board Committees
CommitteeMembers
Audit Committee Seema Manubhai Mehta (Chairperson), Nareshkumar Pirabhai Suthar, Munjal Mahendra Patel
Nomination and remuneration committee Seema Manubhai Mehta (Chairperson), Nareshkumar Pirabhai Suthar, Saurin Jagdish Parikh
Stakeholders Relationship Committee Seema Manubhai Mehta (Chairperson), Mahendra Gulabdas Patel, Hashmukh Ishwarlal Patel
Risk Management Committee Seema Manubhai Mehta (Chairperson), Munjal Mahendra Patel, Darshit Shah
Corporate Social Responsibility Committee Mahendra Gulabdas Patel (Chairperson), Munjal Mahendra Patel, Seema Manubhai Mehta

Charges & Borrowings of Lincoln Pharmaceuticals Ltd

Open charges
₹117.64 Cr
Satisfied charges
₹47 Cr
Breakdown by lending institutions
State Bank of India₹117.64 Cr
Latest charge details
DateLenderAmountStatus
03 Nov 1999 State Bank of India ₹58.82 Cr Open
20 Mar 1999 State Bank of India ₹58.82 Cr Open
24 Sep 2015 Yes Bank Limited ₹10 Cr Satisfied
19 May 2015 Yes Bank Limited ₹13 Cr Satisfied
29 Sep 2010 Idbi Bank Limited ₹20 Cr Satisfied

Total charge records: 6 View all charges

Employees and EPFO Compliance at Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd has a workforce of 1,531 employees as of Feb 25, 2025.

Employee count
1,531
Active EPFO establishments
2
Employee growth
4.72%
Premium access

Employee and EPFO history for Lincoln Pharmaceuticals Ltd

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Lincoln Pharmaceuticals Ltd

Premium access

GST registrations and filing compliance for Lincoln Pharmaceuticals Ltd

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Lincoln Pharmaceuticals Ltd

Premium access

Credit ratings, litigation, and regulatory alerts for Lincoln Pharmaceuticals Ltd

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lincoln Pharmaceuticals Ltd

Premium access

MSME payment history for Lincoln Pharmaceuticals Ltd

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Lincoln Pharmaceuticals Ltd

Premium access

Corporate group structure for Lincoln Pharmaceuticals Ltd

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lincoln Pharmaceuticals Ltd

Premium access

MCA filings and documents for Lincoln Pharmaceuticals Ltd

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Lincoln Pharmaceuticals Ltd

Activity
30 Sep 2025
Lincoln Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Lincoln Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
01 Apr 2024
Nareshkumar Pirabhai Suthar was appointed as a Director on 01 Apr 2024 & has been associated with this company since 2 years 4 months.
Directors
01 Apr 2024
Seema Manubhai Mehta was appointed as a Director on 01 Apr 2024 & has been associated with this company since 2 years 4 months.
Directors
16 Nov 2022
Trusha Kashish Shah was appointed as a Company Secretary on 16 Nov 2022 & has been associated with this company since 3 years 9 months.
Charges
29 Apr 2021
A charge registered on 19 May 2015 via Charge ID 10573870 with Yes Bank Limited was fully satisfied on 29 Apr 2021.

Recent News on Lincoln Pharmaceuticals Ltd

Frequently Asked Questions about Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 20 January 1995 (31+ years old) and is registered under CIN L24230GJ1995PLC024288. The company has 1,531 employees.

Lincoln Pharmaceuticals Ltd reported revenue of ₹671.03 Cr for FY 2026 (up 7.67% YoY) based on consolidated NSE filings.

The current directors of Lincoln Pharmaceuticals Ltd are:

The primary industry of Lincoln Pharmaceuticals Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Lincoln Pharmaceuticals Ltd is a listed company.

Lincoln Pharmaceuticals Ltd can be reached at the registered office: Lincoln House Behind Satyam Complex Science City Road Sola, Ahmedabad, Gujarat, India – 380060, or through the website lincolnpharma.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available